Market revenue in 2023 | USD 20.6 million |
Market revenue in 2030 | USD 30.5 million |
Growth rate | 5.8% (CAGR from 2023 to 2030) |
Largest segment | Crohn's disease |
Fastest growing segment | Ulcerative Colitis |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Crohn's Disease, Ulcerative Colitis |
Key market players worldwide | AbbVie Inc, Takeda Pharmaceutical Co Ltd, Pfizer Inc, Biogen Inc, Novartis AG ADR, Eli Lilly and Co, UCB SA, Merck & Co Inc, Johnson & Johnson, Celltrion Healthcare |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to inflammatory bowel disease treatment market will help companies and investors design strategic landscapes.
Crohn's disease was the largest segment with a revenue share of 57.28% in 2023. Horizon Databook has segmented the Kuwait inflammatory bowel disease treatment market based on crohn's disease, ulcerative colitis covering the revenue growth of each sub-segment from 2018 to 2030.
The pharmaceutical sector in Kuwait is in the growing phase and is mainly driven by government’s healthcare initiatives. An evolving gas and oil industry and limited diversification into other sectors has significantly constrained the pharma manufacturing activities in the country.
Despite having limited diversification for other sectors, the country has one of the best healthcare infrastructures across GCC. Increasing population in Kuwait, changing lifestyle, and rising health issues are creating demand for advanced healthcare infrastructure in the country.
Currently, the country has only one pharmaceutical manufacturing company with high demand for medicines in the country due to burden of various diseases, thus creating opportunities for manufacturers to invest in Kuwait.
Horizon Databook provides a detailed overview of country-level data and insights on the Kuwait inflammatory bowel disease treatment market , including forecasts for subscribers. This country databook contains high-level insights into Kuwait inflammatory bowel disease treatment market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account